首页|运动疗法联合帕立骨化醇治疗MHD伴继发性甲状旁腺功能亢进患者的效果及对其FGF23及Klotho蛋白水平的影响

运动疗法联合帕立骨化醇治疗MHD伴继发性甲状旁腺功能亢进患者的效果及对其FGF23及Klotho蛋白水平的影响

扫码查看
目的 探讨运动疗法联合帕立骨化醇治疗维持性血液透析(MHD)伴继发性甲状旁腺功能亢进(SHPT)患者的效果及对其成纤维细胞生长因子23(FGF23)及Klotho蛋白水平的影响.方法 选取2022年2月—2023年2月建始县第三医院收治的94例MHD合并SHPT患者为研究对象,按照随机数字表法将其分为对照组(n=47)及观察组(n=47).对照组采用帕立骨化醇治疗,观察组在此基础上采用运动疗法治疗.比较两组患者的钙磷代谢情况、血清学相关指标水平及生活质量.结果 治疗后,观察组的血磷水平低于对照组,血钙水平高于对照组,组间差异有统计学意义(P<0.05).治疗后,观察组的Klotho蛋白为(148.15±4.26)μ/L,高于对照组的(143.64±4.26)μ/L,FGF23、全段甲状旁腺激素(iPTH)水平分别为(102.64±10.27)ng/L、(254.43±58.61)ng/L,均低于对照组的(114.26±11.54)ng/L、(324.54±54.14)ng/L,组间差异有统计学意义(P<0.05).治疗后,观察组的肾病相关生存质量量表评分为(69.23±9.36)分,高于对照组的(61.35±8.26)分,差异有统计学意义(P<0.05).结论 采用运动疗法联合帕立骨化醇治疗MHD伴SHPT患者,可调控其iPTH、FGF23 及Klotho蛋白,有效改善钙磷代谢情况,提高生活质量.
Effect of Exercise Therapy Combined with Paricalcitol in the Treatment of MHD Patients with Secondary Hyperparathyroidism and Its Influence on FGF23 and Klotho Protein Levels
Objective To investigate the effect of exercise therapy combined with paricalcitol on maintenance hemodialysis(MHD)patients with secondary hyperparathyroidism(SHPT)and its influence on the levels of fibroblast growth factor 23(FGF23)and Klotho protein.Methods 94 patients with MHD combined with SHPT admitted to Jianshi County Third Hospital from February 2022 to February 2023 were selected as the study objects and were divided into a control group(n=47)and an observation group(n=47)according to the random number table method.The control group was treated with paricalcitol,and the observation group was treated with exercise therapy on this basis.The calcium and phosphorus metabolism,serological indexes level and quality of life were compared between the two groups.Results After treatment,the blood phosphorus level in the observation group was lower than that in the control group,and the blood calcium level was higher than that in the control group,the differences between the two groups were statistically significant(P<0.05).After treatment,the Klotho protein in the observation group was(148.15±4.26)μ/L,which was higher than(143.64±4.26)μ/L in the control group,while the levels of FGF23 and intact parathyroid hormone(iPTH)were(102.64±10.27)ng/L and(254.43±58.61)ng/L,respectively,which were lower than(114.26±11.54)ng/L and(324.54±54.14)ng/L of the control group,the differences between the two groups were statistically significant(P<0.05).After treatment,the kidney disease-targeted areas score in the observation group was(69.23±9.36)points,which was higher than(61.35±8.26)points in the control group,and the difference was statistically significant(P<0.05).Conclusion Exercise therapy combined with paricalcitol in MHD patients with SHPT can regulate iPTH,FGF23 and Klotho protein,effectively improve the metabolism of calcium and phosphorus,and improve the quality of life.

Secondary hyperparathyroidismParicalcitolExercise therapyMaintenance hemodialysisFibroblast growth factor 23

黄庆丰

展开 >

建始县第三医院血液透析室,湖北建始 445300

继发性甲状旁腺功能亢进 帕立骨化醇 运动疗法 维持性血液透析 成纤维细胞生长因子 23

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(3)
  • 15